Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Lorimer

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Postgraduate Medical Journal|January 1, 1976
Indications for beta-adrenoceptor blocking drugs in hypertensionA R Lorimer, J V Jones, B Clark, et al.
Annales De Biologie Clinique|January 1, 1973
Plasma lipid values and prevalence of hyperliproteinaemias in the West of ScotlandA R Lorimer, T D Lawrie, V M Hawthorne, et al.
Haemostasis|January 1, 1987
Severity of coronary artery disease and basal fibrinolysisM Small, G D Lowe, J M Beattie, et al.
British Heart Journal|September 1, 1988
Thrombin and plasmin activity in coronary artery diseaseM Small, G D Lowe, J T Douglas, et al.
Biochemical Society Transactions|January 1, 1976
Low-density-lipoprotein metabolism in type II hyperlipoproteinaemiaC J Packard, J Shepherd, J L Third, et al.
European Journal of Medical Research|October 16, 1995
Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapyA Gaw, C J Packard, G M Lindsay, et al.
British Heart Journal|August 1, 1972
Haemodynamics and myocardial function after sotalolI Hutton, A R Lorimer, W S Hillis, et al.
Metabolism: Clinical and Experimental|September 1, 1976
Low density lipoprotein metabolism in a family of familial hypercholesterolemic patientsC J Packard, J L Third, J Shepherd, et al.
European Journal of Nuclear Medicine|January 1, 1981
Bayesian analysis of stress thallium-201 scintigraphyR G Murray, J H McKillop, R G Bessent, et al.
Lancet (London, England)|February 27, 1982
Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemiaG D Lowe, B M McArdle, P Stromberg, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Postgraduate Medical Journal|January 1, 1976
Indications for beta-adrenoceptor blocking drugs in hypertensionA R Lorimer, J V Jones, B Clark, et al.
Annales De Biologie Clinique|January 1, 1973
Plasma lipid values and prevalence of hyperliproteinaemias in the West of ScotlandA R Lorimer, T D Lawrie, V M Hawthorne, et al.
Haemostasis|January 1, 1987
Severity of coronary artery disease and basal fibrinolysisM Small, G D Lowe, J M Beattie, et al.
British Heart Journal|September 1, 1988
Thrombin and plasmin activity in coronary artery diseaseM Small, G D Lowe, J T Douglas, et al.
Biochemical Society Transactions|January 1, 1976
Low-density-lipoprotein metabolism in type II hyperlipoproteinaemiaC J Packard, J Shepherd, J L Third, et al.
European Journal of Medical Research|October 16, 1995
Metabolism of apolipoprotein B in primary moderate hypercholesterolaemia: effects of acipimox and cholestyramine therapyA Gaw, C J Packard, G M Lindsay, et al.
British Heart Journal|August 1, 1972
Haemodynamics and myocardial function after sotalolI Hutton, A R Lorimer, W S Hillis, et al.
Metabolism: Clinical and Experimental|September 1, 1976
Low density lipoprotein metabolism in a family of familial hypercholesterolemic patientsC J Packard, J L Third, J Shepherd, et al.
European Journal of Nuclear Medicine|January 1, 1981
Bayesian analysis of stress thallium-201 scintigraphyR G Murray, J H McKillop, R G Bessent, et al.
Lancet (London, England)|February 27, 1982
Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemiaG D Lowe, B M McArdle, P Stromberg, et al.
Pageof 15